Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

Peng X, Pentassuglia L, Sawyer DB
Circ Res. 2010 106 (6): 1022-34

PMID: 20360265 · PMCID: PMC2872548 · DOI:10.1161/CIRCRESAHA.109.211276

The race for a cure to cancer continues, fueled by unprecedented discoveries of fundamental biology underlying carcinogenesis and tumorigenesis. The expansion of the target list and tools to approach them is moving the oncology community extraordinarily rapidly to clinical trials, bringing new hope for cancer patients. This effort is also propelling biological discoveries in cardiovascular research, because many of the targets being explored in cancer play fundamental roles in the heart and vasculature. The combined efforts of cardiovascular and cancer biologists, along with clinical investigators in these fields, will be needed to understand how to safely exploit these efforts. Here, we discuss a few of the many research foci in oncology where we believe such collaboration will be particularly important.

MeSH Terms (17)

Animals Antineoplastic Agents Apoptosis Cardiovascular Diseases Cardiovascular System DNA Repair Drugs, Investigational Epigenesis, Genetic Extracellular Matrix Focal Adhesions Humans Integrins Molecular Chaperones Paracrine Communication Proteasome Endopeptidase Complex Risk Assessment Signal Transduction

Connections (1)

This publication is referenced by other Labnodes entities:

Links